These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17689286)

  • 1. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
    Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
    Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
    van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
    Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
    Durand RE; Aquino-Parsons C
    Radiother Oncol; 2006 Aug; 80(2):138-42. PubMed ID: 16916562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
    Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
    Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
    Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
    Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
    Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
    Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.
    Hoskin PJ; Sibtain A; Daley FM; Saunders MI; Wilson GD
    Radiother Oncol; 2004 Aug; 72(2):159-68. PubMed ID: 15297134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
    Wijffels KI; Kaanders JH; Rijken PF; Bussink J; van den Hoogen FJ; Marres HA; de Wilde PC; Raleigh JA; van der Kogel AJ
    Br J Cancer; 2000 Sep; 83(5):674-83. PubMed ID: 10944611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
    Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
    Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
    Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
    Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
    Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
    J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
    Toustrup K; Sørensen BS; Lassen P; Wiuf C; Alsner J; Overgaard J;
    Radiother Oncol; 2012 Jan; 102(1):122-9. PubMed ID: 21996521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.